Publication Records

MICHALEK, Jaroslav, Robert H. COLLINS and Ellen S. VITETTA. Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin. Neoplasma. 2003, vol. 50, No 4, p. 296-299. ISSN 12937844.

COLLINS, Robert, Ellen VITETTA, Victor AQUINO, V. BHUSHAN, P. CHAUDHARY, Robert ILARIA, Jaroslav MICHALEK, Frank NIZZI, John SCHINDLER and Nitin KARANDIKAR. Hematopoietic progenitor cell laboratory manual. Ex-vivo selective depletion of alloreactive donor T lymphocytes using the anti-CD25 immunotoxin RFT5-SMPT-dgA. Dallas, Texas, U.S.A.: UT Southwestern, 2003, 8 pp. UTSW Grand Rounds, 2003.

MICHÁLEK, Jaroslav, Robert H. COLLINS and Ellen S. VITETTA. Prevence reakce štepu proti hostiteli u pacientů podstupujícich alogenní transplantaci hematopoietických kmenových buněk pomocí anti-CD25 imunotoxinu (Prevention of graft-versus-host reaction in patients undergoing hematopoietic stem cell transplant by anti-CD25 immunotoxin). Klinicka onkologie. MOU, 2003, vol. 16, No 4, p. 134-137. ISSN 01355895.

SOLOMON, Scott R., Tao TRAN, Charles S. CARTER, Sandra DONELLY, Naomi HENSEL, John SCHINDLER, Edgar BAHCECI, Viktor GHETIE, Jaroslav MICHALEK, Dan MAVROUDIS, Elan J. READ, Ellen S. VITETTA and A. John BARRETT. Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GVHD prophylaxis in allogeneic peripheral blood stem cell transplantation. Cytotherapy. 2002, vol. 4, No 5, p. 395-406. ISSN 12473206.

MICHALEK, Jaroslav. In vitro selective depletion of alloreactive T cells using an anti-CD25 ricin A chain immunotoxin and immunotoxin enhancers. In University of Texas publication. Dallas, Texas, U.S.A.: University of Texas Southwestern Medical Center, 2001, p. 27-27.

MICHÁLEK, Jaroslav. Imunotoxiny (Immunotoxins). In Monoklonalni protilatky v onkologii. Ed. Zaloudik J. Brno: Grada, 2000, p. 23-29. Pedagogicke publikace. ISBN 01355698.

MICHALEK, Jaroslav, Robert H. COLLINS and Ellen S. VITETTA. The effect of different enhancers on the ability of an anti-CD25 ricin chain immunotoxin to deplete cells which are activated in an MLR. Blood. 2000, vol. 96, No 24, p. 312-312. ISSN 0006-4971.